Back to Search
Start Over
Factors influencing first-line therapy of acute myeloid leukemia (AML) patients (pts) in the Connect MDS/AML Disease Registry
- Source :
- Journal of Clinical Oncology. 36:7037-7037
- Publication Year :
- 2018
- Publisher :
- American Society of Clinical Oncology (ASCO), 2018.
-
Abstract
- 7037Background: Historically, only about 40% of AML pts ≥ 65 y of age receive first-line therapy (1LTx) due to high adverse event and low 5-y survival rates. With the introduction of new agents to ...
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........b4c2e9e62830251cb55d78fe76a852d1
- Full Text :
- https://doi.org/10.1200/jco.2018.36.15_suppl.7037